Lívia Lara Pessoni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lívia Lara Pessoni has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Keila Correia de Alcântara
Universidade Federal de Goiás (UFG), Goiânia, GO, Brazil
2 shared publications- Aline Carvalho Batista
Universidade Federal de Goiás, Brazil
1 shared publication - Anetícia Eduarda Maldaner
Institute of Tropical Pathology and Public Healthy, Universidade Federal de Goiás, Goiânia, Brazil
1 shared publication - Anna Karoline Aguiar Fleuri
Institute of Tropical Pathology and Public Healthy, Universidade Federal de Goiás, Goiânia, Brazil
1 shared publication - Clayson Moura Gomes
Institute of Tropical Pathology and Public Healthy, Universidade Federal de Goiás, Goiânia, Brazil
1 shared publication - Fernanda Bugalho Duarte
Otorhinolaryngology, Hospital Unique, Goiânia, Brazil
1 shared publication
Latest Publications
- Open Access
- 26 February 2021
- Published by Centro Universitario de Maringa in Saúde e Pesquisa
- Vol. 14 (1) , e8666
Reduction in blood donations: the importance of campaing donation in Goiânia, Goiás, Brazil
To analyze the trends of blood donations in a public blood center of Goias, Brazil (HEMOGO – Hemocentro do Estado de Goiás), considering incentive campaigns and transfusion transmissible infection. Retrospective study of the blood donations between 2010-2016. Donors were grouped into autologous, voluntary, replacement and campaign categories. There were 149,983 donations with a reduction of 29% (p
- 26 February 2021
- Published by Centro Universitario de Maringa in Saúde e Pesquisa
- Vol. 14 (1) , e8666
Open AccessReduction in blood donations: the importance of campaing donation in Goiânia, Goiás, Brazil
To analyze the trends of blood donations in a public blood center of Goias, Brazil (HEMOGO – Hemocentro do Estado de Goiás), considering incentive campaigns and transfusion transmissible infection. Retrospective study of the blood donations between 2010-2016. Donors were grouped into autologous, voluntary, replacement and campaign categories. There were 149,983 donations with a reduction of 29% (p
- Open Access
- 1 October 2019
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 41 (4) , 310-315
Prevalence and trends in transfusion-transmissible infections among blood donors in Brazil from 2010 to 2016
- 1 October 2019
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 41 (4) , 310-315
Open AccessPrevalence and trends in transfusion-transmissible infections among blood donors in Brazil from 2010 to 2016
- Open Access
- 1 October 2018
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 40 (4) , 326-331
Red blood cell alloimmunization among hospitalized patients: transfusion reactions and low alloantibody identification rate
- 1 October 2018
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 40 (4) , 326-331
Open AccessRed blood cell alloimmunization among hospitalized patients: transfusion reactions and low alloantibody identification rate
- Open Access
- 9 May 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 1-13
Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10
The interleukin 32 (IL-32) is a proinflammatory cytokine produced by immune and non-immune cells. It can be induced during bacterial and viral infections, but its production was never investigated in protozoan infections. American Tegumentary Leishmaniasis (ATL) is caused by Leishmania protozoan leading to cutaneous, nasal or oral lesions. The aim of this study was to evaluate the expression of IL-32 in cutaneous and mucosal lesions as well as in peripheral blood mononuclear cells (PBMC) exposed to Leishmania (Viannia) braziliensis. IL-32, tumour necrosis factor (TNF) and IL-10 protein expression was evaluated by immunohistochemistry in cutaneous, mucosal lesions and compared to healthy specimens. The isoforms of IL-32α, β, δ, γ mRNA, TNF mRNA and IL-10 mRNA were assessed by qPCR in tissue biopsies of lesions and healthy skin and mucosa. In addition, PBMC from healthy donors were cultured with amastigotes of L. (V.) braziliensis. In lesions, the parasite subgenus was identified by PCR-RFLP. We showed that the mRNA expression of IL-32, in particular IL-32γ was similarly up-regulated in lesions of cutaneous (CL) or mucosal (ML) leishmaniasis patients. IL-32 protein was produced by epithelial, endothelial, mononuclear cells and giant cells. The IL-32 protein expression was associated with TNF in ML but not in CL. IL-32 was not associated with IL-10 in both CL and ML. Expression of TNF mRNA was higher in ML than in CL lesions, however levels of IL-10 mRNA were similar in both clinical forms. In all lesions in which the parasite was detected, L. (Viannia) subgenus was identified. Interestingly, L. (V.) braziliensis induced only IL-32γ mRNA expression in PBMC from healthy individuals. These data suggest that IL-32 plays a major role in the inflammatory process caused by L. (Viannia) sp or that IL-32 is crucial for controlling the L. (Viannia) sp infection.
- 9 May 2014
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 1-13
Open AccessInterleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10
The interleukin 32 (IL-32) is a proinflammatory cytokine produced by immune and non-immune cells. It can be induced during bacterial and viral infections, but its production was never investigated in protozoan infections. American Tegumentary Leishmaniasis (ATL) is caused by Leishmania protozoan leading to cutaneous, nasal or oral lesions. The aim of this study was to evaluate the expression of IL-32 in cutaneous and mucosal lesions as well as in peripheral blood mononuclear cells (PBMC) exposed to Leishmania (Viannia) braziliensis. IL-32, tumour necrosis factor (TNF) and IL-10 protein expression was evaluated by immunohistochemistry in cutaneous, mucosal lesions and compared to healthy specimens. The isoforms of IL-32α, β, δ, γ mRNA, TNF mRNA and IL-10 mRNA were assessed by qPCR in tissue biopsies of lesions and healthy skin and mucosa. In addition, PBMC from healthy donors were cultured with amastigotes of L. (V.) braziliensis. In lesions, the parasite subgenus was identified by PCR-RFLP. We showed that the mRNA expression of IL-32, in particular IL-32γ was similarly up-regulated in lesions of cutaneous (CL) or mucosal (ML) leishmaniasis patients. IL-32 protein was produced by epithelial, endothelial, mononuclear cells and giant cells. The IL-32 protein expression was associated with TNF in ML but not in CL. IL-32 was not associated with IL-10 in both CL and ML. Expression of TNF mRNA was higher in ML than in CL lesions, however levels of IL-10 mRNA were similar in both clinical forms. In all lesions in which the parasite was detected, L. (Viannia) subgenus was identified. Interestingly, L. (V.) braziliensis induced only IL-32γ mRNA expression in PBMC from healthy individuals. These data suggest that IL-32 plays a major role in the inflammatory process caused by L. (Viannia) sp or that IL-32 is crucial for controlling the L. (Viannia) sp infection.